Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF^V600E clone in a newborn affected by high-risk Langerhans cell histiocytosis

Affiliations

• ¹ Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
• ² Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.
• ³ Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy.
• ⁴ Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy.